Marina Chiara Garassino to Mesothelioma
This is a "connection" page, showing publications Marina Chiara Garassino has written about Mesothelioma.
Connection Strength
1.270
-
A lesson from vorinostat in pleural mesothelioma. Lancet Oncol. 2015 Apr; 16(4):359-60.
Score: 0.383
-
NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024. J Natl Compr Canc Netw. 2024 03; 22(2):72-81.
Score: 0.178
-
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. Tumori. 2024 Jun; 110(3):168-173.
Score: 0.178
-
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma. Clin Lung Cancer. 2019 11; 20(6):e652-e660.
Score: 0.129
-
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2019 01; 45(1):75-80.
Score: 0.117
-
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy? Tumori. 2016 Jan-Feb; 102(1):18-30.
Score: 0.100
-
Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol. 2014 Mar; 9(3):390-6.
Score: 0.089
-
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey. Lung Cancer. 2012 Mar; 75(3):360-7.
Score: 0.075
-
?Np63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol. 2013 Jun; 21(3):229-39.
Score: 0.021